🇺🇸 Miacalcin Calcitonin Salmon Nasal Spray in United States

6 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 6

Most-reported reactions

1. Jaw Disorder — 1 report (16.67%)
2. Myalgia — 1 report (16.67%)
3. Osteonecrosis — 1 report (16.67%)
4. Retinal Degeneration — 1 report (16.67%)
5. Retinitis Pigmentosa — 1 report (16.67%)
6. Tooth Infection — 1 report (16.67%)

Source database →

Frequently asked questions

Is Miacalcin Calcitonin Salmon Nasal Spray approved in United States?

Miacalcin Calcitonin Salmon Nasal Spray does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Miacalcin Calcitonin Salmon Nasal Spray in United States?

University of Missouri-Columbia is the originator. The local marketing authorisation holder may differ — check the official source linked above.